×
About 353 results

ALLMedicine™ CMV Retinitis Center

Research & Reviews  80 results

Cytomegalovirus Retinitis and Retinal Detachment following Chimeric Antigen Receptor T ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870699
Current Oncology (Toronto, Ont.); Zu C, Xu Y et. al.

Feb 25th, 2022 - Cytomegalovirus (CMV) retinitis is a rare end-organ disease of CMV infection and is a marker of severe immunosuppression, especially in human immunodeficiency virus (HIV)-positive patients. In multiple myeloma (MM) patients, CMV retinitis has been...

A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir
https://clinicaltrials.gov/ct2/show/NCT00000697

Nov 4th, 2021 - CMV is a common virus, which can cause blindness and death in AIDS patients. Previous studies demonstrate that foscarnet has been effective in both AIDS and non-AIDS patients with CMV infection. Although treatment with ganciclovir (DHPG) is also e...

Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome
https://clinicaltrials.gov/ct2/show/NCT00000726

Nov 3rd, 2021 - Foscarnet is active in vitro (test tube) against herpes viruses, including CMV, by inhibiting the virus DNA polymerases, enzymes necessary for virus replication, without affecting cellular DNA polymerases. Opportunistic CMV disease in AIDS is usua...

see more →

Drugs  41 results see all →

Clinicaltrials.gov  11 results

A Study of Foscarnet in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS Who Cannot Use Ganciclovir
https://clinicaltrials.gov/ct2/show/NCT00000697

Nov 4th, 2021 - CMV is a common virus, which can cause blindness and death in AIDS patients. Previous studies demonstrate that foscarnet has been effective in both AIDS and non-AIDS patients with CMV infection. Although treatment with ganciclovir (DHPG) is also e...

Foscarnet Treatment of Serious CMV Retinitis Infection in Patients With Acquired Immunodeficiency Syndrome
https://clinicaltrials.gov/ct2/show/NCT00000726

Nov 3rd, 2021 - Foscarnet is active in vitro (test tube) against herpes viruses, including CMV, by inhibiting the virus DNA polymerases, enzymes necessary for virus replication, without affecting cellular DNA polymerases. Opportunistic CMV disease in AIDS is usua...

Valganciclovir to Prevent Cytomegalovirus Infection in Kidney and Kidney/Pancreas Transplant Recipients
https://clinicaltrials.gov/ct2/show/NCT00034385

Jul 2nd, 2017 - Cytomegalovirus in solid organ transplant recipients can result in significant morbidity and mortality due to concurrent immunosuppression. Traditionally intravenous followed by oral ganciclovir has been used to prevent and treat cytomegalovirus i...

Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)
https://clinicaltrials.gov/ct2/show/NCT00000136

Oct 22nd, 2015 - CMV retinitis is the most common intraocular infection in patients with AIDS and is estimated to affect 35 to 40 percent of patients with AIDS. Untreated CMV retinitis is a progressive disorder, the end result of which is total retinal destruction...

CMV Retinitis Retreatment Trial
https://clinicaltrials.gov/ct2/show/NCT00000766

Mar 1st, 2011 - Although therapy with foscarnet or ganciclovir halts retinitis progression in 90 percent of patients treated, relapses are common and may accelerate due to development of drug resistance, deteriorating immune function, or other factors. Treatment ...

see more →

News  9 results

EHA 2020 Discussion Addresses New Considerations for Common Transplant Complications
https://www.onclive.com/view/eha-2020-discussion-addresses-new-considerations-for-common-transplant-complications

Dec 20th, 2020 - Following the 2020 European Hematology Association Annual Congress, a panel of hematologic experts came together for a live Q/A session, moderated by Joerg Halter, MD, of the University Hospital Basel in Basel, Switzerland, and Stephan Mielke, MD,...

CMV Retinitis and Cataracts in AIDS
https://www.medscape.com/viewarticle/812671

Oct 25th, 2013 - Risk of Cataract in Persons With Cytomegalovirus Retinitis and the Acquired Immune Deficiency Syndrome Kempen JH, Sugar EA, Lyon AT, et al Ophthalmology. 2012;119:2343-2350 Study Summary Cytomegalovirus (CMV) retinitis is the leading cause of visi...

Roche Adds Drug for CMV Retinitis to Patent Pool, Cutting Price
https://www.medscape.com/viewarticle/808980

Aug 6th, 2013 - LONDON (Reuters) - Roche is to slash the price and pool intellectual property rights on a drug to treat cytomegalovirus retinitis. The move is a further victory for the new Medicines Patent Pool (MPP), which is trying to convince major drugmakers ...

Antisense Drug Gets OK for Inherited High Cholesterol
https://www.medpagetoday.com/cardiology/dyslipidemia/37103

Jan 30th, 2013 - SILVER SPRING, Md. -- The FDA has approved mipomersen (Kynamro) for treating an inherited cholesterol disorder called homozygous familial hypercholesterolemia (HoFH). It's the first antisense oligonucleotide drug for systemic use to win the agency...

CMV Retinitis Increases Cataract Risk in Patients With AIDS
https://www.medscape.com/viewarticle/768666

Aug 3rd, 2012 - August 3, 2012 — Cytomegalovirus (CMV) retinitis is associated with an increased absolute and relative risk for cataract in patients with AIDS, according to a study published online July 31 in Ophthalmology. The risk is highest for patients older ...

see more →